Lymph node-targeted metabolic regulatory nanovaccines to boost cancer immunotherapy by potentiating dendritic cell-mediated antigen presentation

Tumor vaccines represent a promising strategy for the prevention and treatment of cancer. However, suboptimal targeting efficiency to dendritic cells (DCs) and inadequate antigen presentation by metabolically dysfunctional DCs significantly...